Stock Price Quote

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private
BSE635.002.6 (+0.41 %)
PREV CLOSE ( ) 632.40
OPEN PRICE ( ) 636.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4321
TODAY'S LOW / HIGH ( )627.55 648.75
52 WK LOW / HIGH ( )349.5 718.9
NSE636.602.9 (+0.46 %)
PREV CLOSE( ) 633.70
OPEN PRICE ( ) 644.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 636.60 (229)
VOLUME 82137
TODAY'S LOW / HIGH( ) 629.95 644.50
52 WK LOW / HIGH ( )349.25 718.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-06 2002
Management Info
Sura Surendranath Reddy - Chairman - Managing Director
Registered Office

Address 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone 040 2342 0411-12

Email info@vijayadiagnostic.com

Website www.vijayadiagnostic.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

17Feb Vijaya Diagnostic Centre informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
30Jan Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that it enclosed the disclosure un..
22Dec Lupin, Infosys and Vijaya Diagnostic C
Lupin’s consumer healthcare business -- LupinLife has launched Softovac..
22Dec Vijaya Diagnostic Centre rises on comp
Vijaya Diagnostic Centre is currently trading at Rs. 653.70, up by 6.60..
21Dec Vijaya Diagnostic Centre completes acq
Vijaya Diagnostic Centre has completed the acquisition of 100% stake by..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit252.46832.35
Gross Profit 338.37 1112.74
Operating Profit 563.391935.44
Net Sales 1291.184495.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6351.90 (1.95%)
M.Cap ( in Cr)91330.58
Kovai Medical Center (BSE)
peergroup  3741.85 (2.49%)
M.Cap ( in Cr)4094.43
RainbowChildrenS Med (BSE)
peergroup  1298.00 (4.01%)
M.Cap ( in Cr)13174.92
Thyrocare Tech. (BSE)
peergroup  592.20 (5.48%)
M.Cap ( in Cr)3135.86
Max Healthcare Inst (BSE)
peergroup  820.40 (2.08%)
M.Cap ( in Cr)79735.69

Shareholding Pattern

PROMOTERS 54.87%
NON-INSTITUTION 5.36%
MUTUAL FUNDS/UTI 19.41%
FI/BANKS/INSURANCE 0.14%
GOVERNMENT 0%
FII 0%

About Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. was incorporated in the year 2002. Its today's share price is 635. Its current market capitalisation stands at Rs 6498.95 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4495.79 Cr and Total Income of Rs.4641.53 Cr. The company's management includes S Geeta Reddy, Manjula Anagani, Duvvuru Nageshwar Reddy, Shekhar Prasad Singh, Chavali Satyanaraynna Murthy, Sunil Chandra Kondapally, Sura Surendranath Reddy, Hansraj Singh Rajput.

It is listed on the BSE with a BSE Code of 543350 , NSE with an NSE Symbol of VIJAYA and ISIN of INE043W01024. It's Registered office is at 6-3-883/ F , F P A Building,Near Topaz Building,PunjaguttaHyderabad-500082, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.